IL30206A - Process for inactivating microorganisms and/or their antigens - Google Patents
Process for inactivating microorganisms and/or their antigensInfo
- Publication number
- IL30206A IL30206A IL30206A IL3020668A IL30206A IL 30206 A IL30206 A IL 30206A IL 30206 A IL30206 A IL 30206A IL 3020668 A IL3020668 A IL 3020668A IL 30206 A IL30206 A IL 30206A
- Authority
- IL
- Israel
- Prior art keywords
- vaccine
- inactivation
- antigens
- inactivated
- days
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1617350A DE1617350C3 (de) | 1967-06-22 | 1967-06-22 | Verfahren zur Inaktivierung von biologischem Material |
Publications (2)
Publication Number | Publication Date |
---|---|
IL30206A0 IL30206A0 (en) | 1968-08-22 |
IL30206A true IL30206A (en) | 1972-05-30 |
Family
ID=6986788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL30206A IL30206A (en) | 1967-06-22 | 1968-06-19 | Process for inactivating microorganisms and/or their antigens |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS494932B1 (fr) |
AT (1) | AT279041B (fr) |
BE (1) | BE717053A (fr) |
BR (1) | BR6800054D0 (fr) |
CH (1) | CH562612A5 (fr) |
DE (1) | DE1617350C3 (fr) |
FR (2) | FR1588829A (fr) |
IL (1) | IL30206A (fr) |
LU (1) | LU56297A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2748132A1 (de) * | 1977-10-27 | 1979-05-03 | Behringwerke Ag | Stabilisator fuer polysaccharid |
US4456590B2 (en) * | 1981-11-02 | 1989-05-30 | Heat treatment of lyphilized blood clotting factor viii concentrate | |
JPS6013718A (ja) * | 1983-07-05 | 1985-01-24 | Chemo Sero Therapeut Res Inst | B型肝炎ワクチン |
JPS6122331U (ja) * | 1984-07-16 | 1986-02-08 | マルコン電子株式会社 | 回転機用コンデンサ |
JPS6286707A (ja) * | 1985-10-02 | 1987-04-21 | アテシ | 高電圧高エネルギ−密度コンデンサ |
FR2814957B1 (fr) * | 2000-10-06 | 2002-12-20 | Aventis Pasteur | Composition vaccinale et procede de stabilisation |
-
1967
- 1967-06-22 DE DE1617350A patent/DE1617350C3/de not_active Expired
-
1968
- 1968-06-19 IL IL30206A patent/IL30206A/en unknown
- 1968-06-19 LU LU56297D patent/LU56297A1/xx unknown
- 1968-06-20 CH CH916968A patent/CH562612A5/de not_active IP Right Cessation
- 1968-06-20 AT AT590668A patent/AT279041B/de not_active IP Right Cessation
- 1968-06-21 BR BR200054/68A patent/BR6800054D0/pt unknown
- 1968-06-22 JP JP43043344A patent/JPS494932B1/ja active Pending
- 1968-06-24 FR FR1588829D patent/FR1588829A/fr not_active Expired
- 1968-06-24 BE BE717053D patent/BE717053A/xx unknown
- 1968-09-20 FR FR167016A patent/FR8086M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE1617350B2 (de) | 1979-01-11 |
JPS494932B1 (fr) | 1974-02-04 |
FR1588829A (fr) | 1970-03-16 |
FR8086M (fr) | 1970-07-20 |
BE717053A (fr) | 1968-12-24 |
AT279041B (de) | 1970-02-25 |
DE1617350C3 (de) | 1979-09-06 |
IL30206A0 (en) | 1968-08-22 |
BR6800054D0 (pt) | 1973-02-13 |
CH562612A5 (en) | 1975-06-13 |
LU56297A1 (fr) | 1970-01-15 |
DE1617350A1 (de) | 1971-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Seo | Application of radiation technology in vaccines development | |
CA1133829A (fr) | Vaccins contre la pasteurellose | |
CA2968954C (fr) | Compositions contenant des produits biopharmaceutiques inactives mais therapeutiquement actifs, stables a temperature ambiante et procedes de formulation associes | |
US4292307A (en) | Vaccine and method for prophylaxis and treatment of clostridioses of animals and poultry | |
KR100447297B1 (ko) | 개량된불활성백신 | |
IL30206A (en) | Process for inactivating microorganisms and/or their antigens | |
US3859168A (en) | Process of inactivating rabies virus | |
US5807551A (en) | Method to provide artificial passive immunity in birds | |
JPH05508407A (ja) | パスツレラ・ムルトシダのトキソイドワクチン | |
Moges et al. | Veterinary Vaccines: Unlocking the Power of Immunization for Livestock Health—A Review | |
IL30168A (en) | Antigen-free vaccine and process for preparing it | |
CN110507819B (zh) | 青蒿琥酯作为免疫佐剂在制备狂犬病疫苗中的应用 | |
JP3812814B2 (ja) | 動物用多価オイルアジュバントワクチン | |
TW546146B (en) | Erysipelothrix rhusiopathiae antigens and vaccine compositions | |
PT1387693E (pt) | Vacina de micoplasma inactivado por saponina | |
RU2259214C1 (ru) | Способ получения вакцины оспенной инактивированной сухой "оспавир" | |
US11213579B2 (en) | Vaccines with enhanced immunogenicity, low allergenicity and reactogenicity | |
AT410172B (de) | Verfahren zur herstellung einer vakzineformulierung | |
DD298884A5 (de) | Impfstoffe gegen virale antigene und verfahren zu ihrer herstellung | |
RU2822827C1 (ru) | Способ получения препарата вакцины из цельных вирусов или бактерий | |
Cooper et al. | Laboratory studies on the vaccination of mice and turkeys with an Erysipelothrix rhusiopathiae vaccine | |
RU2134590C1 (ru) | Способ изготовления инактивированной вакцины против бешенства животных | |
RU2344832C1 (ru) | Вакцинный препарат против колибактериоза | |
Mahboob et al. | Preparation and evaluation of Newcastle disease oil emulsion vaccine at hydrophile-lipophile balance 7.0 using Mukteswar strain | |
RU2285539C2 (ru) | Молекулярная бивалентная вакцина для профилактики бруцеллеза и диарей, вызванных энтеропатогенными бактериями |